Conjugated estrogens and bazedoxifene and Medroxyprogesterone interaction

Conjugated estrogens and bazedoxifene and Medroxyprogesterone: both prescribing labels describe an interaction that usually calls for monitoring, a dose change, or spacing the doses.

Moderate

Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.

What the FDA labels say

From the Conjugated estrogens and bazedoxifene (Duavee) label · effective 2026-07-31

Moderate

• Women taking DUAVEE should not take progestins, additional estrogens or additional estrogen agonist/antagonists ( 5.1 )

Warnings and precautionsby drug classView label on DailyMed
Moderate

The relative risk associated with combined current and recent use (discontinued use within 5 years before cancer diagnosis) was 1.37 (95% CI 1.27–1.48), and the elevated risk was significant for both estrogen-alone and estrogen plus progestin products.

Warnings and precautionsby drug classView label on DailyMed
Minor

Drugs Containing Progestins, Estrogens or Estrogen Agonist/Antagonists DUAVEE contains conjugated estrogens and bazedoxifene, an estrogen agonist/antagonist.

Warnings and precautionsby drug classView label on DailyMed
Minor

Women taking DUAVEE should not take progestins, additional estrogens or additional estrogen agonist/antagonists.

Warnings and precautionsby drug classView label on DailyMed

From the Medroxyprogesterone (medroxyprogesterone acetate) label · effective 2026-02-23

Moderate

Loss of Bone Mineral Density Use of MPA Injectable Suspension, USP reduces serum estrogen levels and is associated with significant loss of bone mineral density (BMD).

Warnings and precautionsby drug classView label on DailyMed
Moderate

Cancer Risks Breast Cancer Women who have or have had a history of breast cancer should not use hormonal contraceptives, including MPA Injectable Suspension, USP, because breast cancer may be hormonally sensitive [see Contraindications (4) ].

Warnings and precautionsby drug classView label on DailyMed
Moderate

Monitoring A woman who is taking hormonal contraceptive should have a yearly visit with her healthcare professional for a blood pressure check and for other indicated healthcare.

Warnings and precautionsby drug classView label on DailyMed
Moderate

Drugs or herbal products that induce such enzymes may decrease the plasma concentrations of contraceptive hormones, and may decrease the effectiveness of hormonal contraceptives.

Drug interactionsby drug classView label on DailyMed
Moderate

Some drugs or herbal products that may decrease the effectiveness of hormonal contraceptives include: • barbiturates • bosentan • carbamazepine • felbamate • griseofulvin • oxcarbazepine • phenytoin • rifampin • St.

Drug interactionsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.